Albertsons 732R Loratadine Tablets 10mg
- Manufacturer
- BETTER LIVING BRANDS, LLC | TIME CAP LABORATORIES, INC | MARKSANS PHARMA LIMITED
- Effective date
- 2026-04-18
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 01:54:13
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
SPL PATIENT PACKAGE INSERT SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
Active ingredient (in each tablet)
Loratadine USP, 10 mg
OTC - PURPOSE SECTION
Purpose
Antihistamine
INDICATIONS & USAGE SECTION
Uses
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
- runny nose
- itchy, watery eyes
- sneezing
- itching of the nose or throat
WARNINGS SECTION
Warnings
OTC - DO NOT USE SECTION
Do not use if you have ever had an allergic reaction to this product or any of its ingredients.
OTC - ASK DOCTOR SECTION
Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.
OTC - WHEN USING SECTION
When using this product do not take more than directed. Taking more than directed may cause drowsiness.
OTC - STOP USE SECTION
Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
DOSAGE & ADMINISTRATION SECTION
Directions
| adults and children 6 years and over | 1 tablet daily; not more than 1 tablet in 24 hours |
| children under 6 years of age | ask a doctor |
| consumers with liver or kidney disease | ask a doctor |
OTHER SAFETY INFORMATION
Other information
- Tamper evident: do not use this product if the imprinted foil seal over the mouth of the bottle is cut, torn, broken or missing.
- store between 20º to 25º C (68º to 77º F)
- FDA approved dissolution test specifications differ from USP
INACTIVE INGREDIENT SECTION
Inactive ingredients
colloidal silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium starch glycolate
OTC - QUESTIONS SECTION
Questions or comments? Call 1-877-290-4008
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
732R Loratadine 10mg Tablets, 365ct label
732R Loratadine 10mg Tablets, 365ct carton
DailyMed RxNorm Mappings#
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| QR code link | QR Code | 732R carton.jpg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 21130-932-65 | Loratadine 10mg | 365 in 1 BOTTLE | TABLET | 365 | 2 | |
| 21130-932-65 | Loratadine 10mg | 1 in 1 CARTON | TABLET | 1 | 2 |
Products#
Every source-derived product name is available through these pages.
- Loratadine 10mg
- Loratadine
- LACTOSE MONOHYDRATE
- MICROCRYSTALLINE CELLULOSE 101
- MAGNESIUM STEARATE
- SODIUM STARCH GLYCOLATE TYPE A
- SILICON DIOXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 21130-932 | 21130-932-65 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| MICROCRYSTALLINE CELLULOSE 101 | 7T9FYH5QMK | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| SODIUM STARCH GLYCOLATE TYPE A | H8AV0SQX4D | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| LORATADINE | 7AJO3BO7QN | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Loratadine 10mg | LORATADINE | BETTER LIVING BRANDS, LLC | 46d615dd-45d5-2dfc-e063-6394a90a5d42 | 2026-04-18 | Warnings | 21130-932-65 21130-932 21130093265 496f1885-3f87-6a87-e063-6394a90a65a5 46d615dd-45d5-2dfc-e063-6394a90a5d42 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

